title: miRNA-Seq  from serum and cells treated with serum from cancer patients
design: HeLA cells were treated with serum from head and neck scamous cell carcinoma (n=6) and healthy patients (n=4). After 72 hours incubation RNA was extracted for miRNA sequencing. Additionally, the serum from these same cancer and healthy patients was extracted for RNA and submitted for miRNA sequencing.